Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-365. Review.

PMID:
25165049
[PubMed - as supplied by publisher]
Free PMC Article
2.

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria.

Ferreira D, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

Front Aging Neurosci. 2014 Mar 24;6:47. doi: 10.3389/fnagi.2014.00047. eCollection 2014. Review.

PMID:
24715863
[PubMed]
Free PMC Article
3.

Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow.

Cao Z, Yende S, Kellum JA, Robinson RA.

Int J Proteomics. 2013;2013:654356. doi: 10.1155/2013/654356. Epub 2013 Feb 19.

PMID:
23509626
[PubMed]
Free PMC Article
4.

Structure-selective anisotropy assay for amyloid Beta oligomers.

Matveeva EG, Rudolph A, Moll JR, Thompson RB.

ACS Chem Neurosci. 2012 Nov 21;3(11):982-7. doi: 10.1021/cn3001262. Epub 2012 Aug 18.

PMID:
23181170
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.

Keeney JT, Swomley AM, Förster S, Harris JL, Sultana R, Butterfield DA.

Proteomics Clin Appl. 2013 Jan;7(1-2):109-22. doi: 10.1002/prca.201200087. Review.

PMID:
23027708
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.

Kellett KA, Williams J, Vardy ER, Smith AD, Hooper NM.

Int J Mol Epidemiol Genet. 2011;2(2):114-21. Epub 2011 Feb 10.

PMID:
21686125
[PubMed]
Free PMC Article
7.

CSF Biomarkers for Alzheimer's Disease Diagnosis.

Anoop A, Singh PK, Jacob RS, Maji SK.

Int J Alzheimers Dis. 2010 Jun 23;2010. pii: 606802. doi: 10.4061/2010/606802.

PMID:
20721349
[PubMed]
Free PMC Article
8.

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S.

Arch Gen Psychiatry. 2010 Jul;67(7):739-48. doi: 10.1001/archgenpsychiatry.2010.78.

PMID:
20603455
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

Aluise CD, Robinson RA, Beckett TL, Murphy MP, Cai J, Pierce WM, Markesbery WR, Butterfield DA.

Neurobiol Dis. 2010 Aug;39(2):221-8. doi: 10.1016/j.nbd.2010.04.011. Epub 2010 Apr 23.

PMID:
20399861
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk